Loading
Targets move first in preprints. Every week we ask Europe PMC for the bioRxiv, medRxiv and other preprints of the last 90 days that match each target, product and technology, and we check which of them have since appeared as journal articles. Preprints have not been peer reviewed: read them as claims, not findings.
Everything on this page is a preprint unless marked “now in” a journal. Methods, statistics and claims have not been checked by reviewers or editors; some will change and a few will be withdrawn. Nothing here is a treatment recommendation.
Coverage is partial: 3,353 of 3,527 targets, products and technologies have been fetched so far. The weekly workflow resumes from this snapshot and completes the rest; topics not yet covered still have a live preprint feed on their own pages under “Latest papers”.
Preprints in the window that matched each object's literature query. Counts overlap: one preprint can match a target and its drug.
Journal articles from the last 18 months that Europe PMC links back to a preprint on one of these topics. The journal version is the one to cite; the preprint shows how the claim started.
Showing the 150 most recent of 3,269; the per-topic sections below list the rest.